Ken O'Flynn

790. Deputy Ken O'Flynn asked the Minister for Health the reason the southwest HSE region accounts for five of the 18 invasive meningococcal disease cases notified to date in 2026 and four of the 11 serogroup B cases, a disproportionate share relative to its population; if any cluster investigation, outbreak control team, or enhanced surveillance response has been initiated in the southwest region in response to this pattern; and if she will make a statement on the matter. [48998/26]

791. Deputy Ken O'Flynn asked the Minister for Health the current MenB vaccine uptake rate among the eligible infant cohort in the southwest HSE region compared to the national average; and if she will make a statement on the matter. [48999/26]

792. Deputy Ken O'Flynn asked the Minister for Health further to Parliamentary Question No. 2462 of 14 April 2026, if any timeframe targets exist within the HSE or her Department for the period between notification of a meningococcal disease case and completion of contact identification or commencement of post-exposure prophylaxis; if performance against any such timeframe is recorded or monitored; if a dataset exists recording actual response times for meningococcal disease notifications nationally; and if she will make a statement on the matter. [49000/26]

793. Deputy Ken O'Flynn asked the Minister for Health the mechanism in place to escalate or flag a meningococcal disease case where the duty consultant in public health medicine does not undertake the risk assessment described as “immediate” within a defined period; and if she will make a statement on the matter. [49001/26]

795. Deputy Ken O'Flynn asked the Minister for Health the gross expenditure under the GMS, DPS, LTI and high-tech drug scheme for each year of the years 2020 to 2025; whether any formal national mechanism exists to monitor or analyse medicines waste across these schemes; and if no such mechanism exists, whether one is planned and the timeline. [49003/26]

839. Deputy Ken O'Flynn asked the Minister for Health if the HSE has set a national target uptake rate for MenB, MenC and MenACWY vaccines under the Primary Childhood and School Immunisation Programmes; if so, the target for each vaccine; the date by which it is to be achieved; and if she will make a statement on the matter. [49257/26]

840. Deputy Ken O'Flynn asked the Minister for Health given that the National Immunisation Information System will only capture data on children born from 1 October 2025 onward, the specific measures in place to improve immunisation data quality and identify coverage gaps for children born before that date; whether any interim system or process will be introduced to support regional immunisation committees in identifying low-coverage cohorts before the first NIIS report in early 2027; and if she will make a statement on the matter. [49258/26]

841. Deputy Ken O'Flynn asked the Minister for Health to confirm whether any external professional body, advocacy organisation, or international clinical body was consulted on the wording of the 2019 CAAC application; and if none were consulted, to confirm this directly. [49260/26]

842. Deputy Ken O'Flynn asked the Minister for Health to confirm whether any evidential appraisal framework, systematic evidence review, or comparable methodology was applied before WPATH standards of care version seven was referenced in the 2019 CAAC application; and if no such framework exists, to confirm this directly. [49261/26]

843. Deputy Ken O'Flynn asked the Minister for Health to name the specific HSE governance structure, committee, or officeholder that approved the inclusion of WPATH standards of care version seven in the 2019 CAAC application, given that the HSE reply of 23 June 2026 described the post’s approval but did not identify any approving body or individual. [49262/26]

844. Deputy Ken O'Flynn asked the Minister for Health to confirm whether the HSE holds documentary records, including minutes, memoranda, or internal correspondence, relating to the inclusion of WPATH standards of care version seven in the 2019 CAAC application; and if such records exist, to confirm under the retention policy and the duration of period they are held. [49263/26]

845. Deputy Ken O'Flynn asked the Minister for Health if any clinical safety, medico-legal, or child safeguarding assessment was carried out prior to the reference to WPATH Standards of Care Version 7 in the 2019 CAAC application; and if no such assessment was carried out, to confirm this directly. [49264/26]

846. Deputy Ken O'Flynn asked the Minister for Health whether the absence of a centrally recorded number of missed shifts by agency staff supplying workers to HSE-funded services has been identified as a workforce governance risk by her Department; and if she will make a statement on the matter. [49265/26]

847. Deputy Ken O'Flynn asked the Minister for Health if her Department has sought assurance from the HSE that patient safety incidents involving agency staff are captured through any existing reporting mechanism, given the HSE's confirmation that no central record is maintained; and if she will make a statement on the matter. [49266/26]

848. Deputy Ken O'Flynn asked the Minister for Health further to Parliamentary Question No. 698 of 23 June 2026, whether she has raised with the HSE the absence of central tracking of Garda vetting lapses relating to agency staff, given the patient safety implications; and the timeline for HSE response. [49267/26]

849. Deputy Ken O'Flynn asked the Minister for Health whether her Department considers the absence of central recording of credentialing and registration compliance failures among agency staff to be consistent with the assurance framework underpinning HSE national framework agreements; and if she will make a statement on the matter. [49268/26]

850. Deputy Ken O'Flynn asked the Minister for Health further to Parliamentary Question Nos. 687 to 692 of 23 June 2026, the date by which her Department expects the HSE to respond to PQs, all of which received a "service matter" referral with no substantive information provided. [49269/26]

851. Deputy Ken O'Flynn asked the Minister for Health the number of cases handled by the HSE stability and sustainability team since its establishment in 2022, broken down by year; the number of those cases that remain open; and whether a provider has exited the process due to closure or service withdrawal. [49275/26]

852. Deputy Ken O'Flynn asked the Minister for Health the total financial value of rejected PCRS claims for respiratory medicines that remained unpaid in each of the years 2020 t0 2025, and to date in 2026, broken down by year; the reason such a high proportion of rejected claims are never subsequently corrected or reclaimed; whether an assessment has been carried out into the impact of these unrecovered claims on patient access to respiratory medicines; and if she will make a statement on the matter. [49282/26]

853. Deputy Ken O'Flynn asked the Minister for Health the specific decision-making process by which the HSE determines that a drinking water exceedance constitutes a potential danger to human health requiring public-health intervention; the named office or role responsible for making that determination; and whether a documented threshold, beyond the WHO guideline value, triggers mandatory intervention. [49288/26]

854. Deputy Ken O'Flynn asked the Minister for Health further to Parliamentary Question No. 966 of 19 May 2026, the specific audit, consistency-review, or peer-review mechanism that apply to individual treatment abroad scheme eligibility determinations, and if no such mechanism exists, to confirm this directly (details supplied). [49296/26]

855. Deputy Ken O'Flynn asked the Minister for Health further to Parliamentary Question No. 984 of 19 May 2026, to confirm whether any internal audit, financial review, or governance assessment has in fact examined variations in treatment abroad scheme reimbursement costs between jurisdictions for comparable procedures (details supplied); and if no such examination has taken place, to confirm this directly. [49297/26]

856. Deputy Ken O'Flynn asked the Minister for Health further to Parliamentary Question No. 1117 of 19 May 2026, whether the HSE maintains a centralised database recording referrals abroad for gender-related care under the treatment abroad scheme; and if so, which HSE division is responsible for its governance and oversight (details supplied). [49298/26]

857. Deputy Ken O'Flynn asked the Minister for Health further to Parliamentary Question No. 996 of 19 May 2026, to explain the basis for the 2024 figures provided in reply, which show zero applications and zero approvals for paediatric gender-related treatment abroad scheme referrals in that year alongside 13 S2 authorisations issued and expenditure of €62,127.47; and to clarify whether this reflects multi-year processing of prior approvals or some other explanation. [49299/26]

858. Deputy Ken O'Flynn asked the Minister for Health if the HSE intends to introduce a national system for recording and tracking staff grievances and complaints, including time to resolution and referrals to the Workplace Relations Commission; if a timeline has been set for same; and if she will make a statement on the matter. [49303/26]